HTG Medical
It develops automated urine monitoring technology for intensive care units, helping hospitals track patient output after MDR certification.
Overview
HTG Medical builds technology to automate urine monitoring in intensive care units. Its product targets hospitals and ICU teams that need more consistent tracking of patient urine output, a key clinical metric in critical care. The company’s stated differentiators are automation for ICU workflows and secured MDR certification, supporting medical-device compliance in Europe. Its latest disclosed funding is a €450k raise announced alongside the certification.
Funding History
HTG Medical raises €450k and secures MDR certification to automate ICU urine monitoring
Frequently Asked Questions
- How much funding does AI Funding track for HTG Medical?
- AI Funding tracks €450K for HTG Medical across 1 funding round in this database.
- What does HTG Medical do?
- HTG Medical builds technology to automate urine monitoring in intensive care units. Its product targets hospitals and ICU teams that need more consistent tracking of patient urine output, a key clinical metric in critical care. The company’s stated differentiators are automation for ICU workflows and secured MDR certification, supporting medical-device compliance in Europe. Its latest disclosed funding is a €450k raise announced alongside the certification.
- Where is HTG Medical headquartered?
- HTG Medical is headquartered in San Francisco, CA.
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.